Live Breaking News & Updates on Intra Cellular Therapies Inc|Page 2

Stay updated with breaking news from Intra cellular therapies inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Travere Therapeutics "Sparsentan" Market size expansion

Travere Therapeutics "Sparsentan" Market size expansion
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Lumateperone Caplyta , Cellular Therapies Inc , Intra Cellular Therapies Inc , Lumateperone Market Forecast , Lumateperone Market ,

ABVC BioPharma's "ABV-1504" market size expected to increase

ABVC BioPharma's "ABV-1504" market size expected to increase
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Lumateperone Caplyta , Cellular Therapies Inc , Intra Cellular Therapies Inc , Lumateperone Market Forecast , Lumateperone Market ,

Mental health stocks: Innovation and M&A to boost these stocks

Two recent M&A announcements by big pharma are creating excitement among investors. Here's who is poised to benefit. ....

United States , Deloitte Micca , Ken Duckworth , Blair Minter , Richard Close , Neurocrine Biosciences , Canaccord Genuity , Myles Minter , Mackenzie Scott , Marc Goodman , Tema Etfs , Bristol Myers Squibb , Peter Micca , William Blair , Karuna Cerevel , Ashwani Verma , Leerink Goodman , Mental Health , Acadia Pharmaceuticals , Xenon Pharmaceuticals , National Alliance On Mental Illness , Centers For Disease , Institute For Health Metrics , Health Metrics , Global Burden , Cerevel Therapeutics ,

Intra-Cellular Therapies Inc EVP, Chief Medical Officer Suresh Durgam Sells 6,167 Shares

Suresh Durgam, EVP, Chief Medical Officer of Intra-Cellular Therapies Inc (NASDAQ:ITCI), sold 6,167 shares of the company on February 2, 2024, according to a SEC Filing. ....

Cellular Therapies Inc , Intra Cellular Therapies Inc , Possible Value Trap , Think Twice , Iopharmaceutical Company , Chief Medical Officer , Suresh Durgam ,

Intra-Cellular Therapies Inc CEO Sharon Mates Sells 191,362 Shares

Sharon Mates, the Chairman, President & CEO of Intra-Cellular Therapies Inc (NASDAQ:ITCI), has sold 191,362 shares of the company on January 18, 2024, according to a recent SEC Filing. ....

Intra Cellular Therapies Inc , Iopharmaceutical Company , Nsider Transaction , Sharon Mates , Nsider Transactions ,